# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
MDC Partners Inc. ("MDC Partners", "MDC" or the "Company") announced today that MDC shareholders voted ...
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received F...
Dear MDC Shareholders: As a Partner of The Stagwell Group, I am writing to encourage you to vote in favor of the Proposed Tran...
The Special Committee of MDC Partners Inc. ("MDC" or the "Company") responded today to highly misleading, inacc...